Related Experiment Video

Updated: Jun 27, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Post-step modifications for research on HIV vaccines

Lawrence Corey, M Juliana McElrath, James G Kublin

    AIDS (London, England)
    |December 4, 2008
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
    13:36

    Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

    Published on: May 6, 2015

    Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
    10:18

    Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

    Published on: October 16, 2018

    Related Experiment Videos

    Last Updated: Jun 27, 2026

    A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
    14:23

    A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

    Published on: August 31, 2014

    Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
    13:36

    Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

    Published on: May 6, 2015

    Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
    10:18

    Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

    Published on: October 16, 2018

    Related Concept Videos

    Vaccine Production01:23

    Vaccine Production

    Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Correlates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccine.

    NPJ vaccines·2026

    Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposures.

    Frontiers in immunology·2026

    Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials.

    Vaccine·2026

    Controlled human infection with Mycobacterium tuberculosis: practical considerations for clinical trials.

    The Lancet. Microbe·2026

    Association between COVID-19 vaccine efficacy and epidemic force of infection.

    NPJ vaccines·2026

    Sex-based differences in Plasmodium infection in the control groups of controlled human malaria infection trials in malaria-naive populations in the USA and the Netherlands: a pooled analysis.

    The Lancet. Microbe·2026

    Methylation patterns linked to blood pressure in people with HIV exposed to ART reveal neurovascular and immune pathways: The MACS/WIHS Combined Cohort Study.

    AIDS (London, England)·2026

    HIV-related stigma, antiretroviral adherence, and viral suppression among women with HIV: the role of anxiety and patient-provider relationship.

    AIDS (London, England)·2026

    Impact of influenza and pneumococcal vaccines on inflammatory response during suppressive antiretroviral therapy.

    AIDS (London, England)·2026

    CD4+ cell count trends after common cancers in people with HIV: a multicohort collaboration.

    AIDS (London, England)·2026

    HIV-1 soluble gp120 in cerebrospinal fluid is associated with poorer motor domain neurocognitive performance in virally suppressed people with HIV.

    AIDS (London, England)·2026

    Vascular risk drives cognitive decline over 10 years in people aging with well-controlled HIV.

    AIDS (London, England)·2026

    Purification of Advanced Therapeutics by Flow-Through Pseudo-Affinity Chromatography: Bi-Specific mABs, Fc Fusion Proteins, and Adeno-Associated Viruses.

    Biotechnology and bioengineering·2026

    Myelin Alteration in Neurodevelopmental Disorders: Integrating Clinical and Preclinical Evidence.

    Current neuropharmacology·2026

    Patient Communication Outside of Visits: Implications for Remote Monitoring and Digital Care Models in Myasthenia Gravis.

    Muscle & nerve·2026

    Enhanced transcriptional insulation of lentiviral vectors using "sequence-upgraded polyA long terminal repeats" or "supA-LTRs".

    Molecular therapy. Advances·2026

    Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.

    Open forum infectious diseases·2026

    Chronic migraine management with onabotulinumtoxinA and anti-CGRP/R monoclonal antibodies in an Italian real-world setting: update on therapeutic appropriateness and an emerging role of pharmacy.

    Frontiers in pharmacology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us